AONN+ Signs Cancer Leadership Council Letter on Disability Reviews

Press Releases published on February 4, 2020 in News & Updates

AONN+ signs letter regarding SA-2018---26, Rules Regarding the Frequency and Notice of Continuing Disability Reviews, to decrease the burden on people with cancer and their families with proposed repeated reviews for continuation of disability benefits.

Download PDF

Related Items
AONN+ Represents at Access USA Conference in March
News & Updates published on April 3, 2026 in News & Updates
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, recently traveled to Philadelphia to represent AONN+ at the Access USA Conference, specifically for Patient Assistance & Access Programs. Here, she took part in the highly popular panel, “The Medicare Patient Experience: Affordability, Access, and the State of Healthcare Today,” which focused on financial burdens that patients with chronic illnesses face and why the work to improve access is far from finished. 
The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program
Press Releases published on June 2, 2025 in News & Updates
Gainesville, Fla. (June 1, 2025) – The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a groundbreaking grant program in partnership with Gilead Sciences aimed at advancing the field of oncology navigation and enhancing patient outcomes within the healthcare setting. This initiative is designed to support the creation, enhancement, and expansion of innovative tools that optimize efficiency and elevate the critical role of oncology navigators.
The Academy of Oncology Nurse & Patient Navigators Welcomes Rani Khetarpal as President of Board of Trustees
Press Releases published on May 22, 2025 in News & Updates
Gainesville, Fla. (May 22, 2025) – The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to announce that long-time member, and seasoned healthcare executive Rani Khetarpal, MBA, has been announced as President of its Board of Trustees for a term that will run through 2027.